News
A shocking report on mifepristone has finally shown a light on how the FDA is harming, and even killing, thousands of women.
Hosted on MSN1mon
Debate over the abortion pill mifepristone resurfaces after Makary is confirmed to head the FDAIn recent testimony before the Senate health committee, Makary wouldn’t commit to specific action on the pill, called mifepristone, despite prodding from both Republicans and Democrats.
More than one in 10 women may experience serious complications, such as hemorrhaging or severe infection, from medication ...
The manufacturers, Danco (which makes and markets the name-brand abortion pill Mifeprex) and GenBioPro (which makes and markets the generic version, mifepristone), also insist that their trials ...
Food and Drug Administration Commissioner Martin Makary said Thursday he has “no plans to take action” to restrict the availability of mifepristone, the pill used in most medication abortions ...
Food and Drug Administration (FDA) Commissioner Marty Makary said he has no plans to change current policy to restrict access to the abortion pill mifepristone, despite a steady pressure campaign ...
Makary said in an interview at the Semafor World Economy Summit that he has “no plans to take action” to restrict mifepristone, the pill used in nearly two-thirds of abortions in the United ...
Here's what to know about the safety of mifepristone, which is typically used with misoprostol in medication abortions that make up close to two-thirds of abortions in the U.S. The FDA approved ...
THE SUPREME COURT, IN A UNANIMOUS DECISION, PRESERVED ACCESS TO THE ABORTION DRUG MIFEPRISTONE, REPRODUCE RIGHTS REMAIN A KEY FOCUS IN THE PRESIDENT’S RACE WITH THIS DECISION. WITH THIS DECISION ...
In recent testimony before the Senate health committee, Makary wouldn’t commit to specific action on the pill, called mifepristone, despite prodding from both Republicans and Democrats.Medical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results